Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 350 of 3284 entries
View as:

ARAMIS: Actions of tesaglitazaR on fAt Metabolism and Insulin Sensitivity

Phase: N/A Priority: Normal
NCT ID: NCT00263965 Org: User:
Start: 08/31/05 End: 07/31/06 Due: 07/31/07

Accessorized Pre-Filled Syringe to Autoinjector Pharmacokinetic Bridging Study in Anifrolumab

Phase: N/A Priority: Normal
NCT ID: NCT05339100 Org: User:
Start: 03/22/22 End: 04/13/23 Due: 04/13/24

A Study To Evaluate the Effect of Rosuvastatin On Intravascular Ultrasound-Derived Coronary Atheroma Burden (ASTEROID)

Phase: N/A Priority: Normal
NCT ID: NCT00240318 Org: User:
Start: 11/30/02 End: 11/30/05 Due: 11/30/06

Evaluate Saxagliptin in Adult Indian Patients With Type 2 Diabetes Inadequate Glycemic Control

Phase: N/A Priority: Normal
NCT ID: NCT00918879 Org: User:
Start: 05/31/09 End: 07/31/10 Due: 07/31/11

Nexium Capsules RE Maintenance Specific Clinical Experience Investigation

Phase: N/A Priority: Normal
NCT ID: NCT01562639 Org: User:
Start: 04/30/12 End: 07/31/14 Due: 07/31/15

Survey of Lipid Goal Attainment and Mortality in Patients With High Cardiovascular Risk in Thailand

Phase: N/A Priority: Normal
NCT ID: NCT00684151 Org: User:
Start: 04/30/08 End: 11/30/11 Due: 11/30/12

An Open Label Prostate Cancer Study in Japanese Patients

Phase: N/A Priority: Normal
NCT ID: NCT01351688 Org: User:
Start: 08/31/11 End: 05/31/13 Due: 05/31/14

Efficacy Observational Study of Candesartan Cilexetil on Hypertensive Patients

Phase: N/A Priority: Normal
NCT ID: NCT00573742 Org: User:
Start: 09/30/07 End: 02/29/08 Due: 02/28/09

Study to Investigate the Management of Hypertension and Efficacy of AZD2171 in Patients With Advanced Solid Tumours

Phase: N/A Priority: Normal
NCT ID: NCT00264004 Org: User:
Start: 11/30/05 End: 04/30/11 Due: 04/30/12

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of AZD5462 Following Single and Multiple Ascending Dose Administration to Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT04994106 Org: User:
Start: 07/27/21 End: 09/20/22 Due: 09/20/23

Treatment of Hypertension in Primary Care in Spain

Phase: N/A Priority: Normal
NCT ID: NCT00868881 Org: User:
Start: 03/31/09 End: 07/31/09 Due: 07/31/10

A Disease Registry of Patients With Mantle Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT03816683 Org: User:
Start: 04/01/19 End: 03/18/24 Due: 03/18/25

Trial of Iressa in Prostate Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00265070 Org: User:
Start: 01/31/03 End: 08/31/11 Due: 08/31/12

Canadian Ticagrelor Survey

Phase: N/A Priority: Normal
NCT ID: NCT01757483 Org: User:
Start: 11/30/12 End: 12/31/14 Due: 12/31/15

Evaluation of Efficacy and Safety of Fostamatinib Monotherapy Compared With Adalimumab Monotherapy in Patients With Rheumatoid Arthritis (RA)

Phase: N/A Priority: Normal
NCT ID: NCT01264770 Org: User:
Start: 01/31/11 End: 08/31/13 Due: 08/31/14

DETECT-Register DocumEnTation and Evaluation of a COPD Combination Therapy

Phase: N/A Priority: Normal
NCT ID: NCT02552160 Org: User:
Start: 09/24/15 End: 12/31/17 Due: 12/31/18

Study to Examine the Effect on Glucose Control and Safety/Tolerability of Exenatide Given Two Times a Day to Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00111540 Org: User:
Start: 11/30/02 End: 09/30/06 Due: 09/30/07

Patient Palatability and Preference of 3 Potassium Binders in Patients With Chronic Kidney Disease and Hyperkalaemia

Phase: N/A Priority: Normal
NCT ID: NCT04566653 Org: User:
Start: 10/23/20 End: 01/12/22 Due: 01/12/23

Comparing the Efficacy and Tolerability of Fulvestrant 500 mg Versus 250 mg in Advanced Breast Cancer Women

Phase: N/A Priority: Normal
NCT ID: NCT01300351 Org: User:
Start: 03/31/11 End: 03/31/14 Due: 03/31/15

Long-Term Organ Damage: Anifrolumab Versus Real-World Standard of Care in Adult Patients With Active Systemic Lupus Erythematosus

Phase: N/A Priority: Normal
NCT ID: NCT06485674 Org: User:
Start: 05/09/24 End: 05/30/25 Due: 05/30/26

A Study to Evaluate CIN-107 for the Treatment of Patients With Uncontrolled Hypertension and Chronic Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT05432167 Org: User:
Start: 04/29/22 End: 05/02/24 Due: 05/02/25

Casodex 150-mg Compassionate Use Trial for Subjects With Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00636259 Org: User:
Start: - End: - Due: -

DETERMINE-reduced - Dapagliflozin Effect on Exercise Capacity Using a 6-minute Walk Test in Patients With Heart Failure With Reduced Ejection Fraction

Phase: N/A Priority: Normal
NCT ID: NCT03877237 Org: User:
Start: 04/09/19 End: 03/07/20 Due: 03/07/21

Open Label Prostate Cancer Study

Phase: N/A Priority: Normal
NCT ID: NCT01162395 Org: User:
Start: 08/31/10 End: 10/31/15 Due: 10/31/16

An ADME Study of [14C]AZD0780 in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05817461 Org: User:
Start: 04/19/23 End: 06/06/23 Due: 06/06/24